RCT Abstract - Mirtazapine to alleviate severe breathlessness in patients with COPD or ILD: an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial (BETTER-B).
Year: 2024
Type: conference-abstract
Authors: Irene Higginson, Sarah T Brown, Adejoke O Oluyase, Peter May, Matthew Maddocks, Massimo Costantini, Sabrina Bajwah, Charles Normand, Claudia Bausewein, Steffen T Simon, Karen Ryan, David C Currow, Miriam J Johnson, Simon P Hart, Hannah Mather, Malgorzata Krajnik, Silvia Tanzi, Luca Ghirotto, Charlotte E Bolton, Piotr Janowiak, Elena Turola, Caroline J Jolley, Andrew Wilcock, Geraldine Murden, Bobbie Farsides, Julia M Brown
Institutions: King's College London, University of Leeds, LMU Klinikum, Ludwig-Maximilians-Universität München, University Hospital Cologne, University College Dublin, Mater Misericordiae University Hospital, University of Wollongong, University of Hull, Hull York Medical School, Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz, University of Nottingham, Nottingham Biomedical Research Centre, Gdańsk Medical University, Nottingham University Hospitals NHS Trust, Brighton and Sussex Medical School, University of Sussex
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404127309